PACB Pacific Biosciences of California, Inc. - Common Stock
$1.46
가격 · 8월 25, 2026
기준 재무 정보 8월 6, 2026
52주 범위
$1–$3
23% of range
애널리스트 평점
BUY
14 analysts
목표 주가
$2
+58% upside
P/E (TTM)
-0.8
ROE
-1634.9%
순이익률
-341.5%
Pacific Biosciences of California, Inc. - Common Stock 정보 위키백과 회사 개요
Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.
더 보기
Pacific Biosciences of California, Inc. (a.k.a. PacBio) is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.
History
The company was founded based on research done at Cornell University that combined semiconductor processing and photonics with biotechnology research. Three graduate students in the lab of Professors Watt W. Webb — Jonas Korlach — and Harold Craighead — Steve Turner and Mathieu Foquet — became the first employees.
It began under the name Nanofluidics, Inc. The company raised nearly US$400,000,000 in six rounds of primarily venture capital financing, making it one of the most capitalized startups in 2010 leading up to their public offering in October of that year. Key investors included Mohr Davidow Ventures, Kleiner, Perkins, Caufield & Byers, Alloy Ventures, and Wellcome Trust.
The company's first commercial product, the PacBio RS, was sold to a limited set of customers in 2010 and was commercially released in early 2011. A subsequent version of the sequencer called the PacBio RS II was released in April 2013.
Leadership
In 2004, Kleiner Perkins entrepreneur-in-residence Hugh Martin became CEO. On 6 January 2012 board member Michael Hunkapiller, PhD assumed the role of CEO. Hunkapiller retired in September 2020, and was replaced by chairman of the board Christian Henry. Henry was a former executive VP and chief commercial officer of Illumina before joining the board at PacBio in July 2018.
Illumina: attempted acquisition
On 1 November 2018, Illumina, Inc. agreed to purchase PacBio for US$1.2 billion in cash. The deal was expected to close in the fourth quarter of 2019. In December 2019, the Federal Trade Commission sued to block the acquisition. The deal was abandoned with an announcement on 2 January 2020. Illumina further agreed to pay Pacific Biosciences a $98 million US termination fee plus previously agreed upon deal extension payments of $22 million US in February and $6 million US in March 2020.
Sequencing technology
Sequencing instruments
The company's first scientific instrument, called the PacBio RS, was released to a limited set of customers in late 2010., with full commercial release in early 2011. Sequencing provider GATC Biotech was selected by Pacific Biosciences as its first European service provider in late 2010. A new version of the sequencer was released in April 2013 it produced longer sequence reads and higher throughput than the original RS instrument. The RS instrument will officially be supported until the end of 2021. In September 2015, the company released a new sequencing instrument, the Sequel System, with increased sequencing capacity at a smaller size and lower price compared to the PacBio RS II. Subsequently, in October 2022, PacBio launched a new sequencing system, which can sequence 1,300 human genomes per year as compared to 86 per year of the previous PacBio sequencing machines.
Reagents and SMRT Cells
To use either instrument, customers must also purchase reagent packs for DNA preparation and sequencing and small consumables called "SMRT Cells." Cells for early forms of the sequencer are slightly less than one-centimeter square and contains tens of thousands of zero-mode waveguides, whereas newer systems have a higher density of cells and contain 25 million zero-mode waveguides (ZMWGs), allowing for faster DNA sequencing.
Software and applications
Their secondary analysis bioinformatics product for the RS, called “SMRT Analysis”, was open source. For the Sequel system the secondary analysis software was reorganized as the "SMRT Link" application. In 2013, the company released new bioinformatics tools for automated genome assembly (HGAP) and finishing (Quiver).
출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗
PACB 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$1.46
시가총액
$452M
P/E (TTM)
-0.8
EPS (TTM)
$-1.82
매출 (TTM)
$160M
배당 수익률
—
ROE
-1634.9%
부채/자본
—
52주 범위
$1 – $3
PACB 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
$160M
2016-12-31
→
2025-12-31
EPS
$-1.82
2018-12-31
→
2025-12-31
잉여현금흐름
$-114M
2016-12-31
→
2025-12-31
마진
-341.5%
2016-12-31
→
2025-12-31
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
PACB
동종업계 중앙값
P/E (TTM)
-0.8
17.5
P/S (TTM)
2.8
3.3
P/B
84.5
2.1
Price / FCF (주가 / FCF)
-4.0
—
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
PACB
동종업계 중앙값
Gross Margin (매출 총이익률)
28.6%
42.5%
Operating Margin (영업이익률)
-346.1%
—
Net Profit Margin (순이익률)
-341.5%
-56.5%
ROA
-53.4%
-17.2%
ROE
-1634.9%
-41.3%
ROIC
-10360.5%
—
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
PACB
동종업계 중앙값
Current Ratio (유동비율)
5.1
4.9
Quick Ratio (당좌 비율)
4.3
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
PACB
동종업계 중앙값
Revenue YoY (매출 YoY)
3.9%
—
Revenue CAGR 3Y (매출 CAGR 3년)
7.6%
—
Revenue CAGR 5Y (매출 CAGR 5년)
15.2%
—
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
PACB
동종업계 중앙값
PACB 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
14 명의 애널리스트
- 적극 매수 4 28.6%
- 매수 5 35.7%
- 보유 4 28.6%
- 매도 1 7.1%
- 적극 매도 0 0.0%
12개월 목표 주가
6 명의 애널리스트 · 2026-08-21
중앙값
$2.50
평균
$2.29
지금
$1.46
저가
$1.25
고가
$3.00
중앙값 목표
$2.50
+71.8%
평균 목표
$2.29
+57.5%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
-0.19%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $-0.14 | $-0.13 | -0.01% |
| 2026년 3월 31일 | $-0.12 | $-0.14 | 0.02% |
| 2025년 12월 31일 | $-0.12 | $-0.15 | 0.03% |
| 2025년 9월 30일 | $-0.13 | $-0.15 | 0.03% |
| 2025년 6월 30일 | $-0.14 | $-0.17 | 0.03% |
| 2025년 3월 31일 | $-1.44 | $-0.19 | -1.2% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| PACB | $565M | -1.0 | 3.9% | -341.5% | -1634.9% | 28.6% |
| CYRX | $479M | 6.9 | 12.4% | 44.4% | 15.3% | 47.1% |
| MLAB | $489M | 73.1 | 3.4% | 2.7% | 3.7% | 63.5% |
| OABI | — | — | — | — | — | — |
| CTKB | $649M | 505.0 | 0.52% | -33.0% | -18.5% | 51.8% |
| DNA | $484M | -1.5 | -25.1% | -183.8% | -55.8% | — |
| TKNO | $204M | -11.9 | 7.3% | -42.6% | -23.8% | 33.2% |
| LAB | $495M | -6.4 | -6.2% | -87.8% | -17.6% | 49.9% |
| QSI | — | — | — | — | — | — |
| LFCR | $249M | -5.3 | 0.47% | -30.0% | -461.3% | 31.3% |
| CDXS | $147M | -3.3 | 18.6% | -62.5% | -82.8% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 17
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $160M | $154M | $201M | $128M | $131M | $79M | $91M | $79M | $93M | $91M | $93M | $61M | |
| Cost of Revenue | $114M | $117M | $148M | $79M | $72M | $46M | $56M | $54M | $59M | $47M | $39M | $37M | |
| Gross Profit | $46M | $37M | $53M | $49M | $59M | $33M | $35M | $25M | $35M | $44M | $53M | $23M | |
| R&D Expense | $97M | $135M | $187M | $193M | $113M | $64M | $60M | $63M | $65M | $68M | $60M | $48M | |
| SG&A Expense | $141M | $175M | $170M | $161M | $124M | $73M | $75M | $63M | $59M | $48M | $45M | $38M | |
| Operating Expenses | $600M | $512M | $387M | $356M | $269M | $137M | $135M | $126M | $124M | $115M | $83M | $86M | |
| Operating Income | $-554M | $-474M | $-334M | $-307M | $-210M | $-104M | $-101M | $-101M | $-90M | $-71M | $-29M | $-63M | |
| Interest Expense | · | · | $14M | $15M | $13M | $267.0K | $3M | $2M | $3M | $3M | $3M | $3M | |
| Other Non-op | $15M | $24M | $33M | $8M | $93.0K | $2M | $1M | $848.0K | $516.0K | $103.0K | $364.0K | $-478.0K | |
| Pretax Income | $-546M | $-310M | $-318M | $-314M | $-275M | $29M | $-84M | · | · | · | · | · | |
| Income Tax | $318.0K | $316.0K | $-11M | $0 | $-94M | · | · | · | · | · | · | · | |
| Net Income | $-546M | $-310M | $-307M | $-314M | $-181M | $29M | $-84M | $-103M | $-92M | $-74M | $-32M | $-66M | |
| EPS (Basic) | $-1.82 | $-1.13 | $-1.21 | $-1.40 | $-0.89 | $0.18 | $-0.55 | $-0.76 | · | · | · | · | |
| EPS (Diluted) | $-1.82 | $-1.59 | $-1.21 | $-1.40 | $-0.89 | $0.17 | $-0.55 | $-0.76 | · | · | · | · | |
| Shares (Basic) | 299,959,000 | 274,488,000 | 253,629,000 | 224,550,000 | 204,136,000 | 165,187,000 | 152,527,000 | 135,094,000 | · | · | · | · | |
| Shares (Diluted) | 299,959,000 | 288,366,000 | 253,629,000 | 224,550,000 | 204,136,000 | 174,970,000 | 152,527,000 | 135,094,000 | · | · | · | · | |
| EBITDA | $-554M | $-474M | $-334M | $-307M | $-210M | $-104M | $-101M | $-94M | $-81M | $-67M | $-25M | $-59M |
대차대조표 30
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $64M | $55M | $180M | $325M | $461M | $82M | $30M | $19M | $17M | $17M | $34M | $36M | |
| Short-term Investments | $216M | $335M | $452M | $447M | $584M | $237M | $19M | $84M | $46M | $55M | $49M | $65M | |
| Receivables | $35M | $28M | $37M | $19M | $24M | $17M | $15M | $9M | $13M | $11M | $5M | $3M | |
| Inventory | $49M | $59M | $57M | $50M | $25M | $14M | $13M | $18M | $23M | $16M | $11M | $11M | |
| Prepaid Expense | $11M | $19M | $17M | $10M | $7M | $5M | $3M | $3M | $2M | $10M | $12M | $2M | |
| Other Current Assets | · | · | · | · | · | · | · | · | $931.0K | $476.0K | $741.0K | $107.0K | |
| Current Assets | $375M | $496M | $742M | $852M | $1.10B | $356M | $81M | $132M | $102M | $109M | $111M | $118M | |
| PP&E (Net) | $24M | $31M | $36M | $42M | $33M | $25M | $30M | $34M | $38M | $15M | $9M | $7M | |
| PP&E (Gross) | $117M | $112M | $111M | $107M | $89M | $75M | $74M | $71M | $70M | $52M | $42M | $37M | |
| Accum. Depreciation | $92M | $82M | $75M | $65M | $56M | $50M | $44M | $37M | $32M | $37M | $34M | $30M | |
| Goodwill | $318M | $318M | $462M | $410M | $410M | · | · | · | · | · | · | · | |
| Intangibles | $15M | $390M | $457M | $410M | $411M | · | · | · | · | · | · | · | |
| Other Non-current Assets | $9M | $9M | $13M | $11M | $1M | $43.0K | $42.0K | $43.0K | $45.0K | $10M | $8M | $29.0K | |
| Total Assets | $784M | $1.26B | $1.75B | $1.77B | $2.01B | $414M | $148M | $170M | $144M | $138M | $131M | $124M | |
| Accounts Payable | $21M | $17M | $15M | $12M | $11M | $4M | $8M | $7M | $9M | $8M | $5M | $6M | |
| Accrued Liabilities | $34M | $23M | $46M | $33M | $36M | $17M | $13M | $13M | $13M | $17M | $16M | $11M | |
| Short-term Debt | · | $0 | $490.0K | $2M | $2M | · | $16M | · | · | · | · | · | |
| Current Liabilities | $73M | $66M | $95M | $263M | $72M | $39M | $49M | $27M | $29M | $34M | $38M | $31M | |
| Capital Leases | $57M | $15M | $32M | $41M | $50M | $38M | $42M | · | · | · | · | $2M | |
| Other Non-current Liabilities | $0 | $546.0K | $751.0K | $1M | $3M | $752.0K | · | · | · | $2M | $1M | $2M | |
| Total Liabilities | $779M | $754M | $1.04B | $1.20B | $1.22B | $78M | $93M | $56M | $58M | $53M | $58M | $69M | |
| Long-term Debt | · | · | · | $897M | $896M | · | $16M | $15M | $14M | $16M | · | $14M | |
| Total Debt | · | $0 | $490.0K | $2M | $2M | · | $16M | · | · | · | · | · | |
| Common Stock | $302.0K | $294.0K | $268.0K | $227.0K | $221.0K | $192.0K | $153.0K | $150.0K | $116.0K | $93.0K | $80.0K | $74.0K | |
| Paid-in Capital | $2.70B | $2.65B | $2.54B | $2.10B | $2.01B | $1.37B | $1.12B | $1.10B | $966M | $872M | $787M | $736M | |
| Retained Earnings | $-2.70B | $-2.15B | $-1.84B | $-1.53B | $-1.22B | $-1.04B | $-1.07B | $-982M | $-880M | $-788M | $-713M | $-681M | |
| AOCI | $457.0K | $422.0K | $219.0K | $-5M | $-1M | $85.0K | $5.0K | $-36.0K | $-32.0K | $5.0K | $-7.0K | $9.0K | |
| Stockholders' Equity | $5M | $507M | $701M | $563M | $791M | $335M | $55M | $114M | $86M | $85M | $74M | $55M | |
| Liabilities + Equity | $784M | $1.26B | $1.75B | $1.77B | $2.01B | $414M | $148M | $170M | $144M | $138M | $131M | $124M | |
| Shares Outstanding | 301,956,000 | 294,418,000 | 267,744,000 | 226,505,000 | 220,978,000 | 192,294,000 | 153,119,000 | 150,244,000 | 116,277,000 | 92,677,000 | 79,983,000 | 73,927,000 |
현금 흐름 16
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | $7M | $8M | $4M | $4M | $4M | |
| Stock-based Comp | $42M | $71M | $72M | $79M | $73M | $18M | $16M | $23M | $20M | $20M | $14M | $10M | |
| Deferred Tax | $-546.0K | $-205.0K | $-11M | $0 | $-94M | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $369M | $27M | $8M | $913.0K | $0 | $0 | $0 | · | · | · | · | · | |
| Restructuring | · | $13M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | $6M | $-4M | $-17M | $-34M | $528.0K | |
| Operating Cash Flow | $-111M | $-206M | $-259M | $-263M | $-111M | $20M | $-78M | $-66M | $-68M | $-68M | $-48M | $-51M | |
| CapEx | $3M | $6M | $9M | $17M | $6M | $1M | $3M | $2M | $10M | $8M | $3M | $2M | |
| Investing Cash Flow | $115M | $124M | $5M | $116M | $-679M | $-219M | $62M | $-38M | $-2M | $-15M | · | · | |
| Stock Issued | $0 | $0 | $189M | $0 | $32M | $46M | $9M | $10M | $9M | $8M | $7M | $4M | |
| Net Stock Activity | $0 | $0 | $15M | $11M | $32M | $46M | $9M | $10M | $9M | $8M | $7M | $4M | |
| Financing Cash Flow | $3M | $-43M | $109M | $10M | $1.17B | $252M | $27M | $107M | $69M | $66M | · | · | |
| Net Change in Cash | $8M | $-125M | $-146M | $-138M | $380M | · | · | · | $-258.0K | $-17M | $-3M | $10M | |
| Taxes Paid | $481.0K | $256.0K | $140.0K | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-114M | $-212M | $-268M | $-280M | $-117M | $18M | $-81M | $-68M | $-78M | $-76M | $-51M | $-53M | |
| Levered FCF | · | · | $-282M | · | $-125M | · | · | · | · | · | · | · |
수익성 8
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 28.6% | 24.2% | 26.3% | 38.2% | 45.1% | 41.3% | 38.0% | 31.9% | 37.1% | 48.7% | 57.6% | 38.6% | |
| Operating Margin | -346.1% | -308.0% | -166.8% | -239.4% | -161.2% | -132.3% | -110.6% | -128.4% | -96.1% | -78.5% | -31.4% | -103.7% | |
| Net Margin | -341.5% | -201.2% | -153.0% | -244.9% | -138.8% | 37.3% | -92.6% | -130.4% | -98.6% | -82.0% | -34.2% | -109.2% | |
| Pretax Margin | -341.3% | -201.0% | -158.7% | -244.9% | -210.6% | · | · | · | · | · | · | · | |
| EBITDA Margin | -346.1% | -308.0% | -166.8% | -239.4% | -161.2% | -132.3% | -110.6% | -119.3% | -87.0% | -74.3% | -27.4% | -96.8% | |
| ROA | -53.4% | -20.6% | -17.5% | -16.7% | -15.0% | 10.5% | -52.9% | -65.2% | -65.4% | -55.3% | -24.8% | -50.7% | |
| ROE | -1634.9% | -64.6% | -41.9% | -52.8% | -22.2% | 12.7% | -158.8% | -83.4% | -108.0% | -94.0% | -49.3% | -106.6% | |
| ROIC | -10360.5% | -93.7% | -46.0% | · | -17.5% | · | · | · | · | · | · | · |
유동성 및 지급능력 4
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.1 | 7.5 | 7.8 | 3.2 | 15.4 | 9.2 | 1.6 | 4.9 | 3.5 | 3.2 | 2.9 | 3.7 | |
| Quick Ratio | 4.3 | 6.3 | 7.0 | 3.0 | 14.9 | 8.7 | 1.3 | 4.1 | 2.7 | 2.5 | 2.3 | 3.3 | |
| Debt / Equity | · | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.3 | · | · | · | · | · | |
| Interest Coverage | · | · | -23.3 | -20.9 | -16.8 | -391.0 | -38.5 | -41.7 | -30.7 | -22.0 | -10.0 | -22.2 |
효율성 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 | 0.6 | 0.5 | 0.7 | 0.7 | 0.7 | 0.5 | |
| Inventory Turnover | 2.1 | 2.0 | 2.8 | 2.1 | 3.7 | 3.4 | 3.6 | 2.6 | 3.0 | 3.5 | 3.5 | 3.5 | |
| Receivables Turnover | 5.1 | 4.8 | 7.2 | 6.0 | 6.4 | 4.9 | 7.6 | 7.1 | 7.5 | 10.9 | 21.4 | 19.7 |
성장률 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 3.9% | -23.2% | 56.3% | -1.7% | 65.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.6% | 5.7% | 36.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 15.2% | · | · | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM) 14
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $160M | $154M | $201M | $128M | $131M | $79M | $91M | $79M | $93M | $91M | $93M | $61M | |
| Net Income TTM | $-546M | $-310M | $-307M | $-314M | $-181M | $29M | $-84M | $-103M | $-92M | $-74M | $-32M | $-66M | |
| Market Cap | $565M | $539M | $2.63B | $1.85B | $4.52B | $4.99B | $787M | $1.11B | $307M | $352M | $1.05B | $580M | |
| Enterprise Value | · | $149M | $2.00B | $1.08B | $3.48B | · | $754M | · | · | · | · | · | |
| P/E | -1.0 | -1.2 | -8.1 | -5.8 | -23.0 | 152.6 | -9.3 | -9.7 | · | · | · | · | |
| P/S | 3.5 | 3.5 | 13.1 | 14.4 | 34.6 | 63.2 | 8.7 | 14.1 | 3.3 | 3.9 | 11.3 | 9.6 | |
| P/B | 105.6 | 1.1 | 3.7 | 3.3 | 5.7 | 14.9 | 14.3 | 9.7 | 3.6 | 4.2 | 14.3 | 10.5 | |
| P / Tangible Book | · | · | · | · | · | 14.9 | · | · | · | · | · | · | |
| P / Cash Flow | -5.1 | -2.6 | -10.1 | -7.0 | -40.7 | 255.8 | -10.0 | -16.7 | -4.5 | -5.2 | -21.9 | -11.3 | |
| P / FCF | -5.0 | -2.5 | -9.8 | -6.6 | -38.6 | 270.2 | -9.7 | -16.3 | -3.9 | -4.6 | -20.6 | -10.9 | |
| EV / EBITDA | · | -0.3 | -6.0 | -3.5 | -16.5 | · | -7.5 | · | · | · | · | · | |
| EV / FCF | · | -0.7 | -7.4 | -3.9 | -29.7 | · | -9.3 | · | · | · | · | · | |
| EV / Revenue | · | 1.0 | 10.0 | 8.4 | 26.7 | · | 8.3 | · | · | · | · | · | |
| Earnings Yield | -97.3% | -86.9% | -12.3% | -17.1% | -4.3% | 0.66% | -10.7% | -10.3% | · | · | · | · |
손익계산서 17
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $39M | $37M | $45M | $38M | $40M | $37M | $39M | $40M | $36M | $39M | $58M | $56M | $48M | $39M | $27M | $32M | |
| Cost of Revenue | $26M | $24M | $28M | $23M | $25M | $39M | $29M | $30M | $30M | $28M | $49M | $38M | $32M | $29M | $22M | $19M | |
| Gross Profit | $13M | $13M | $17M | $16M | $15M | $-1M | $10M | $10M | $6M | $11M | $10M | $18M | $16M | $10M | $5M | $14M | |
| R&D Expense | $23M | $20M | $23M | $23M | $23M | $29M | $27M | $26M | $38M | $43M | $45M | $48M | $46M | $49M | $43M | $47M | |
| SG&A Expense | $33M | $31M | $34M | $31M | $36M | $40M | $42M | $44M | $46M | $44M | $46M | $43M | $41M | $40M | $45M | $37M | |
| Operating Expenses | $57M | $21M | $58M | $55M | $60M | $428M | $163M | $74M | $182M | $93M | $97M | $100M | $89M | $101M | $92M | $88M | |
| Operating Income | $-45M | $-8M | $-41M | $-39M | $-45M | $-429M | $-153M | $-64M | $-176M | $-81M | $-88M | $-82M | $-73M | $-91M | $-87M | $-75M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $4M | · | $4M | $4M | $4M | · | $4M | |
| Other Non-op | $2M | $2M | $3M | $3M | $5M | $4M | $4M | $7M | $6M | $7M | $8M | $9M | $9M | $7M | $6M | $1M | |
| Pretax Income | $-45M | $-8M | $-40M | $-38M | $-42M | $-426M | $3M | $-61M | $-173M | $-78M | $-83M | $-78M | $-70M | $-88M | $-84M | $-77M | |
| Income Tax | $58.0K | $184.0K | $202.0K | $383.0K | $35.0K | $-302.0K | $316.0K | $0 | $0 | $0 | $-718.0K | $-11M | $0 | $0 | $0 | $0 | |
| Net Income | $-45M | $-8M | $-40M | $-38M | $-42M | $-426M | $2M | $-61M | $-173M | $-78M | $-82M | $-67M | $-70M | $-88M | $-84M | $-77M | |
| EPS (Basic) | $-0.14 | $-0.03 | $-0.11 | $-0.13 | $-0.14 | $-1.44 | $0.02 | $-0.22 | $-0.64 | $-0.29 | $-0.31 | $-0.26 | $-0.28 | $-0.36 | $-0.37 | $-0.34 | |
| EPS (Diluted) | $-0.14 | $-0.03 | $-0.11 | $-0.13 | $-0.14 | $-1.44 | $-0.44 | $-0.22 | $-0.64 | $-0.29 | $-0.31 | $-0.26 | $-0.28 | $-0.36 | $-0.37 | $-0.34 | |
| Shares (Basic) | 310,655,000 | 305,819,000 | -597,905,000 | 300,844,000 | 300,162,000 | 296,858,000 | -540,390,000 | 272,915,000 | 272,385,000 | 269,578,000 | -493,474,000 | 255,001,000 | 250,070,000 | 242,032,000 | -447,361,000 | 225,123,000 | |
| Shares (Diluted) | 310,655,000 | 305,819,000 | -597,905,000 | 300,844,000 | 300,162,000 | 296,858,000 | -526,512,000 | 272,915,000 | 272,385,000 | 269,578,000 | -493,474,000 | 255,001,000 | 250,070,000 | 242,032,000 | -447,361,000 | 225,123,000 | |
| EBITDA | $-45M | $-8M | · | $-39M | $-45M | $-429M | · | $-64M | $-176M | $-81M | · | $-82M | $-73M | $-91M | · | $-75M |
대차대조표 27
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $61M | $56M | $64M | $56M | $55M | $59M | $55M | $78M | $100M | $77M | $180M | $386M | $209M | $354M | $325M | $304M | |
| Short-term Investments | $176M | $220M | $216M | $242M | $260M | $285M | $335M | $393M | $410M | $485M | · | $382M | $621M | $521M | · | $530M | |
| Receivables | $31M | $29M | $35M | $31M | $32M | $32M | $28M | $29M | $32M | $30M | · | $30M | $24M | $30M | · | $23M | |
| Inventory | $61M | $51M | $49M | $53M | $54M | $54M | $59M | $66M | $69M | $67M | · | $68M | $68M | $62M | · | $43M | |
| Prepaid Expense | $10M | $13M | $11M | $12M | $12M | $15M | $19M | $17M | $17M | $17M | · | $15M | $14M | $14M | · | $13M | |
| Current Assets | $339M | $370M | $375M | $394M | $413M | $445M | $496M | $584M | $628M | $677M | · | $882M | $936M | $981M | · | $914M | |
| PP&E (Net) | $27M | $24M | $24M | $22M | $23M | $25M | $31M | $32M | $35M | $37M | · | $40M | $40M | $41M | · | $39M | |
| PP&E (Gross) | · | · | $117M | · | · | · | $112M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $92M | · | · | · | $82M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $318M | $318M | $318M | $318M | $318M | $318M | $318M | $369M | $369M | $462M | · | $464M | $410M | $410M | · | $410M | |
| Intangibles | $13M | $14M | $15M | $16M | $17M | $18M | $390M | $436M | $443M | $450M | · | $462M | $410M | $410M | · | $410M | |
| Other Non-current Assets | $13M | $14M | $9M | $9M | $9M | $9M | $9M | $10M | $10M | $10M | · | $13M | $13M | $13M | · | $1M | |
| Total Assets | $752M | $782M | $784M | $803M | $825M | $861M | $1.26B | $1.45B | $1.51B | $1.67B | · | $1.90B | $1.85B | $1.90B | · | $1.82B | |
| Accounts Payable | $19M | $14M | $21M | $16M | $15M | $14M | $17M | $12M | $17M | $21M | · | $16M | $17M | $17M | · | $13M | |
| Accrued Liabilities | $30M | $34M | $34M | $29M | $27M | $29M | $23M | $19M | $22M | $22M | · | $35M | $27M | $19M | · | $25M | |
| Current Liabilities | $69M | $65M | $73M | $63M | $60M | $67M | $66M | $60M | $78M | $73M | · | $184M | $271M | $266M | · | $82M | |
| Capital Leases | $60M | $59M | $57M | $54M | $52M | $50M | $15M | $17M | $20M | $29M | · | $34M | $37M | $39M | · | $43M | |
| Other Non-current Liabilities | $8M | $8M | $0 | $0 | $0 | $0 | $546.0K | $751.0K | $751.0K | $751.0K | · | $1M | $837.0K | $969.0K | · | $2M | |
| Total Liabilities | $785M | $780M | $779M | $767M | $764M | $769M | $754M | $997M | $1.02B | $1.02B | · | $1.13B | $1.21B | $1.20B | · | $1.19B | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $897M | · | $897M | |
| Common Stock | $311.0K | $311.0K | $302.0K | $302.0K | $300.0K | $300.0K | $294.0K | $274.0K | $272.0K | $272.0K | · | $258.0K | $250.0K | $250.0K | · | $226.0K | |
| Paid-in Capital | $2.72B | $2.71B | $2.70B | $2.69B | $2.68B | $2.67B | $2.65B | $2.60B | $2.58B | $2.57B | · | $2.52B | $2.33B | $2.31B | · | $2.08B | |
| Retained Earnings | $-2.75B | $-2.70B | $-2.70B | $-2.65B | $-2.62B | $-2.58B | $-2.15B | $-2.15B | $-2.09B | $-1.92B | · | $-1.76B | $-1.69B | $-1.62B | · | $-1.45B | |
| AOCI | $-503.0K | $-147.0K | $457.0K | $415.0K | $267.0K | $381.0K | $422.0K | $2M | $-523.0K | $-306.0K | · | $-2M | $-3M | $-2M | · | $-6M | |
| Stockholders' Equity | $-33M | $2M | $5M | $36M | $61M | $92M | $507M | $453M | $493M | $649M | $701M | $764M | $642M | $692M | $563M | $627M | |
| Liabilities + Equity | $752M | $782M | $784M | $803M | $825M | $861M | $1.26B | $1.45B | $1.51B | $1.67B | · | $1.90B | $1.85B | $1.90B | · | $1.82B | |
| Shares Outstanding | 310,810,000 | 310,487,000 | 301,956,000 | 301,853,000 | 300,350,000 | 300,041,000 | 294,418,000 | 273,812,000 | 272,491,000 | 272,280,000 | 267,744,000 | 258,374,000 | 250,473,000 | 249,803,000 | 226,505,000 | 225,916,000 |
현금 흐름 12
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $9M | $4M | $10M | $11M | $12M | $9M | $16M | $18M | $17M | $20M | $17M | $20M | $18M | $18M | $18M | $19M | |
| Amort. of Intangibles | · | $1M | $1M | $1M | $1M | $366M | $7M | $7M | $7M | $7M | $7M | $942.0K | $232.0K | $234.0K | $228.0K | $229.0K | |
| Restructuring | · | · | · | · | · | · | · | · | $11M | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-36M | $-45M | $-19M | $-19M | $-29M | $-44M | $-31M | $-45M | $-54M | $-76M | $-58M | $-65M | $-42M | $-95M | $-61M | $-63M | |
| CapEx | $2M | $3M | $861.0K | $-86.0K | $550.0K | $1M | $2M | $-787.0K | $1M | $4M | $2M | $830.0K | $2M | $4M | $5M | $4M | |
| Investing Cash Flow | $40M | $36M | $26M | $19M | $25M | $45M | $58M | $23M | $77M | $-34M | $-67M | $242M | $-99M | $-73M | $80M | $54M | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $189M | $0 | $-6M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $189M | · | · | |
| Financing Cash Flow | $255.0K | $1M | $0 | $1M | $0 | $2M | $-50M | $812.0K | $-152.0K | $7M | $-82M | $-781.0K | $-5M | $196M | $819.0K | $3M | |
| Net Change in Cash | $5M | $-7M | $7M | $2M | $-4M | $3M | $-23M | $-22M | $22M | $-103M | $-206M | $176M | $-145M | $29M | $21M | $-6M | |
| Free Cash Flow | · | $-48M | · | · | · | $-45M | · | · | · | $-80M | · | · | · | $-98M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-83M | · | · | · | $-102M | · | · |
수익성 8
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 32.4% | 34.5% | · | 41.4% | 36.9% | -3.7% | · | 25.0% | 16.5% | 29.1% | · | 32.1% | 32.7% | 25.1% | · | 41.9% | |
| Operating Margin | -114.4% | -22.5% | · | -101.1% | -112.8% | -1154.5% | · | -160.3% | -488.3% | -209.6% | · | -148.1% | -153.8% | -234.6% | · | -230.9% | |
| Net Margin | -114.7% | -22.3% | · | -98.9% | -105.4% | -1146.8% | · | -151.9% | -481.3% | -201.4% | · | -120.1% | -146.8% | -226.3% | · | -238.2% | |
| Pretax Margin | -114.5% | -21.8% | · | -97.9% | -105.4% | -1147.6% | · | -151.9% | -481.3% | -201.4% | · | -139.3% | -146.8% | -226.3% | · | -238.2% | |
| EBITDA Margin | -114.4% | -22.5% | · | -101.1% | -112.8% | -1154.5% | · | -160.3% | -488.3% | -209.6% | · | -148.1% | -153.8% | -234.6% | · | -230.9% | |
| ROA | -5.7% | -1.0% | · | -3.4% | -3.6% | -33.7% | · | -3.6% | -10.3% | -4.4% | · | -3.6% | -3.8% | -4.6% | · | -4.0% | |
| ROE | -316.5% | -17.6% | · | -15.5% | -15.1% | -115.1% | · | -10.0% | -30.6% | -11.7% | · | -9.6% | -10.5% | -12.3% | · | -10.5% | |
| ROIC | 134.5% | -361.2% | · | -108.8% | -73.0% | -467.7% | · | -14.1% | -35.7% | -12.5% | · | -9.3% | -11.4% | -13.2% | · | · |
유동성 및 지급능력 3
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.9 | 5.7 | · | 6.2 | 6.9 | 6.7 | · | 9.7 | 8.0 | 9.3 | · | 4.8 | 3.4 | 3.7 | · | 11.2 | |
| Quick Ratio | 3.9 | 4.7 | · | 5.2 | 5.8 | 5.6 | · | 8.3 | 6.9 | 8.1 | · | 4.3 | 3.1 | 3.4 | · | 10.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -22.8 | · | -23.0 | -20.6 | -25.1 | · | -20.4 |
효율성 3
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.4 | 0.4 | 0.6 | · | 0.4 | 0.4 | 0.4 | · | 0.7 | 0.6 | 0.6 | · | 0.6 | |
| Receivables Turnover | 1.2 | 1.2 | · | 1.3 | 1.2 | 1.2 | · | 1.3 | 1.3 | 1.3 | · | 2.1 | 1.9 | 1.4 | · | 1.4 |
가치 평가 (TTM) 9
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $154M | $153M | · | $155M | $153M | $152M | · | $170M | $178M | $181M | · | $174M | $154M | $140M | · | $136M | |
| Net Income TTM | $-133M | $-514M | · | $-567M | $-702M | $-738M | · | $-379M | $-388M | $-303M | · | $-302M | $-306M | $-318M | · | $-213M | |
| Market Cap | $522M | $410M | · | $386M | $372M | $354M | · | $465M | $373M | $1.02B | · | $2.16B | $3.33B | $2.89B | · | $1.31B | |
| P/E | -3.8 | -0.8 | · | -0.7 | -0.5 | -0.5 | · | -1.2 | -0.9 | -3.2 | · | -6.7 | -10.2 | -8.3 | · | -6.1 | |
| P/S | 3.4 | 2.7 | · | 2.5 | 2.4 | 2.3 | · | 2.7 | 2.1 | 5.6 | · | 12.4 | 21.6 | 20.7 | · | 9.7 | |
| P/B | -15.7 | 173.2 | · | 10.7 | 6.1 | 3.9 | · | 1.0 | 0.8 | 1.6 | · | 2.8 | 5.2 | 4.2 | · | 2.1 | |
| P / Cash Flow | · | -9.2 | · | · | · | -8.0 | · | · | · | -13.5 | · | · | · | -30.5 | · | · | |
| P / FCF | · | -8.6 | · | · | · | -7.8 | · | · | · | -12.8 | · | · | · | -29.4 | · | · | |
| Earnings Yield | -26.2% | -131.8% | · | -150.8% | -196.8% | -219.5% | · | -82.9% | -107.3% | -31.7% | · | -14.8% | -9.8% | -12.0% | · | -16.4% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | $160M | $154M | $201M | $128M | $131M |
| 매출 총이익률 % | 28.6% | 24.2% | 26.3% | 38.2% | 45.1% |
| 영업이익률 % | -346.1% | -308.0% | -166.8% | -239.4% | -161.2% |
| 순이익 | $-546M | $-310M | $-307M | $-314M | $-181M |
| 희석 EPS | $-1.82 | $-1.59 | $-1.21 | $-1.40 | $-0.89 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 | — | 0.0 | 0.0 | 0.0 | 0.0 |
| 유동비율 | 5.1 | 7.5 | 7.8 | 3.2 | 15.4 |
| 당좌 비율 | 4.3 | 6.3 | 7.0 | 3.0 | 14.9 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-114M | $-212M | $-268M | $-280M | $-117M |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 248개의 제출자 · $274.5M 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
기관 활동 — Q2 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 25 (-29 이전 분기 대비) | 28 (-2 이전 분기 대비) | 67 (+12 이전 분기 대비) | 81 (+4 이전 분기 대비) | -4.7M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| ARK Investment Management LLC | $50,032,778 | 29,781,416 | 18.23% | 주식 |
| SOFTBANK GROUP CORP. | $34,358,638 | 20,451,570 | 12.52% | 주식 |
| VANGUARD GROUP INC | $28,083,542 | 15,017,937 | 10.23% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $22,508,529 | 13,397,934 | 8.20% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $10,951,905 | 6,516,920 | 3.99% | 주식 |
| Sumitomo Mitsui Trust Group, Inc. | $10,096,321 | 6,009,715 | 3.68% | 주식 |
| Amova Asset Management Americas, Inc. | $10,036,224 | 6,009,715 | 3.66% | 주식 |
| STATE STREET CORP | $10,014,774 | 5,961,175 | 3.65% | 주식 |
| Point72 Asset Management, L.P. | $8,042,664 | 4,787,300 | 2.93% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $7,127,566 | 4,242,599 | 2.60% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $6,656,903 | 3,962,442 | 2.43% | 주식 |
| Point72 (DIFC) Ltd | $5,465,775 | 4,270,137 | 1.99% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $4,488,819 | 2,671,916 | 1.64% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4,455,861 | 2,652,298 | 1.62% | 주식 |
| D. E. Shaw & Co., Inc. | $3,959,804 | 2,357,026 | 1.44% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $3,675,213 | 2,187,627 | 1.34% | 주식 |
| Longaeva Partners L.P. | $3,558,628 | 2,118,231 | 1.30% | 주식 |
| GOLDMAN SACHS GROUP INC | $3,262,914 | 1,942,211 | 1.19% | 주식 |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | $2,846,837 | 1,694,546 | 1.04% | 주식 |
| Birchview Capital, LP | $2,268,000 | 1,350,000 | 0.83% | 주식 |
| BlackRock, Inc. | $2,210,561 | 1,315,810 | 0.81% | 주식 |
| BANK OF AMERICA CORP /DE/ | $1,812,811 | 1,079,054 | 0.66% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $1,623,216 | 966,200 | 0.59% | 주식 |
| BOURNE LENT ASSET MANAGEMENT INC | $1,584,332 | 943,055 | 0.58% | 주식 |
| TWO SIGMA ADVISERS, LP | $1,547,425 | 827,500 | 0.56% | 주식 |
| HHLR ADVISORS, LTD. | $1,543,739 | 918,892 | 0.56% | 주식 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $1,358,616 | 808,700 | 0.49% | 주식 |
| Casdin Capital, LLC | $1,215,929 | 723,767 | 0.44% | 주식 |
| TUDOR INVESTMENT CORP ET AL | $1,150,308 | 684,707 | 0.42% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $1,095,649 | 652,172 | 0.40% | 주식 |
| XTX Topco Ltd | $1,073,322 | 638,882 | 0.39% | 주식 |
| Numerai GP LLC | $1,044,068 | 621,469 | 0.38% | 주식 |
| CARRET ASSET MANAGEMENT, LLC | $1,008,235 | 600,140 | 0.37% | 주식 |
| Man Group plc | $1,003,521 | 597,334 | 0.37% | 주식 |
| Balyasny Asset Management L.P. | $948,090 | 564,339 | 0.35% | 주식 |
| PEAK6 LLC | $933,327 | 555,552 | 0.34% | 주식 |
| Vestmark Advisory Solutions, Inc. | $803,384 | 478,205 | 0.29% | 주식 |
| ArrowMark Colorado Holdings LLC | $786,882 | 468,382 | 0.29% | 주식 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $741,954 | 441,639 | 0.27% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $673,008 | 400,600 | 0.25% | 풋 옵션 |
| RHUMBLINE ADVISERS | $599,738 | 356,996 | 0.22% | 주식 |
| CAXTON ASSOCIATES LP | $577,087 | 315,348 | 0.21% | 주식 |
| Mirador Capital Partners LP | $575,370 | 342,482 | 0.21% | 주식 |
| LPL Financial LLC | $567,003 | 337,502 | 0.21% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $566,071 | 336,947 | 0.21% | 주식 |
| Connor, Clark & Lunn Investment Management Ltd. | $529,407 | 315,123 | 0.19% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $510,919 | 387,060 | 0.19% | 주식 |
| Qube Research & Technologies Ltd | $500,558 | 297,951 | 0.18% | 주식 |
| Nuveen Asset Management, LLC | $494,437 | 270,184 | 0.18% | 주식 |
| GROUP ONE TRADING LLC | $488,645 | 290,860 | 0.18% | 주식 |
| WATER ISLAND CAPITAL LLC | $459,759 | 273,666 | 0.17% | 주식 |
| HSBC HOLDINGS PLC | $457,555 | 277,306 | 0.17% | 주식 |
| BARCLAYS PLC | $447,482 | 266,359 | 0.16% | 주식 |
| WELLS FARGO & COMPANY/MN | $430,196 | 256,069 | 0.16% | 주식 |
| Bank of New York Mellon Corp | $426,179 | 253,678 | 0.16% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $406,056 | 241,700 | 0.15% | 콜 옵션 |
| Quadrature Capital Ltd | $311,899 | 185,654 | 0.11% | 주식 |
| Green Alpha Advisors, LLC | $300,140 | 178,655 | 0.11% | 주식 |
| MARSHALL WACE, LLP | $274,919 | 163,642 | 0.10% | 주식 |
| UBS Group AG | $271,868 | 161,826 | 0.10% | 주식 |
| MetLife Investment Management, LLC | $264,093 | 157,198 | 0.10% | 주식 |
| RAYMOND JAMES FINANCIAL INC | $260,524 | 155,074 | 0.09% | 주식 |
| AdvisorNet Financial, Inc | $255,565 | 152,122 | 0.09% | 주식 |
| Main Street Research LLC | $255,528 | 152,100 | 0.09% | 주식 |
| JANE STREET GROUP, LLC | $255,192 | 151,900 | 0.09% | 콜 옵션 |
| Voleon Capital Management LP | $226,521 | 134,834 | 0.08% | 주식 |
| ENVESTNET ASSET MANAGEMENT INC | $223,315 | 132,926 | 0.08% | 주식 |
| IEQ CAPITAL, LLC | $207,954 | 123,782 | 0.08% | 주식 |
| CITIGROUP INC | $206,867 | 123,135 | 0.08% | 주식 |
| Vanguard Global Advisers, LLC | $204,592 | 121,781 | 0.07% | 주식 |
| Koa Wealth Management, LLC | $201,600 | 120,000 | 0.07% | 주식 |
| Invesco Ltd. | $188,456 | 112,176 | 0.07% | 주식 |
| CITADEL ADVISORS LLC | $186,144 | 110,800 | 0.07% | 콜 옵션 |
| BENJAMIN EDWARDS INC | $179,922 | 107,153 | 0.07% | 주식 |
| KAVAR CAPITAL PARTNERS GROUP, LLC | $173,576 | 103,319 | 0.06% | 주식 |
| Bridgewater Associates, LP | $172,638 | 102,761 | 0.06% | 주식 |
| GABELLI FUNDS LLC | $168,000 | 100,000 | 0.06% | 주식 |
| CITADEL ADVISORS LLC | $152,964 | 91,050 | 0.06% | 주식 |
| NEW YORK STATE COMMON RETIREMENT FUND | $142,506 | 84,825 | 0.05% | 주식 |
| Police & Firemen's Retirement System of New Jersey | $134,324 | 79,955 | 0.05% | 주식 |
| NJ State Employees Deferred Compensation Plan | $128,000 | 100,000 | 0.05% | 주식 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $126,573 | 75,341 | 0.05% | 주식 |
| HUB Investment Partners, LLC | $126,000 | 75,000 | 0.05% | 주식 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $120,861 | 71,941 | 0.04% | 주식 |
| HARTLINE INVESTMENT CORP/ | $115,920 | 69,000 | 0.04% | 주식 |
| Cerity Partners LLC | $115,811 | 68,935 | 0.04% | 주식 |
| STIFEL FINANCIAL CORP | $114,659 | 68,249 | 0.04% | 주식 |
| INTECH INVESTMENT MANAGEMENT LLC | $113,249 | 67,410 | 0.04% | 주식 |
| SIMPLEX TRADING, LLC | $110,307 | 65,659 | 0.04% | 주식 |
| CITADEL ADVISORS LLC | $109,536 | 65,200 | 0.04% | 풋 옵션 |
| Nuveen, LLC | $99,117 | 58,998 | 0.04% | 주식 |
| VOYA INVESTMENT MANAGEMENT LLC | $96,004 | 57,145 | 0.03% | 주식 |
| CAPTRUST FINANCIAL ADVISORS | $94,854 | 56,461 | 0.03% | 주식 |
| Cetera Investment Advisers | $91,834 | 54,663 | 0.03% | 주식 |
| State of Wyoming | $91,169 | 54,267 | 0.03% | 주식 |
| MERCER GLOBAL ADVISORS INC /ADV | $86,972 | 51,769 | 0.03% | 주식 |
| Abacus Planning Group, Inc. | $86,080 | 51,238 | 0.03% | 주식 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $85,770 | 54,981 | 0.03% | 주식 |
| Evolution Wealth Advisors, LLC | $84,000 | 50,000 | 0.03% | 주식 |
| China Universal Asset Management Co., Ltd. | $83,046 | 49,432 | 0.03% | 주식 |
회사 내부자 30 명의 내부자 · 6 임원 · 11 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Mark Van Oene | President & CEO | 2026년 8월 17일 S | 2,705,853 | 0 | 4 | $-335,122 |
| Susan K Barnes | EVP, CFO and PAO | 2020년 2월 19일 S | 874,812 | 0 | 0 | $0 |
| James Michael Phillips | SVP, Research & Development | 2020년 3월 24일 S | 249,220 | 0 | 0 | $0 |
| Kevin P Corcoran | SVP, Market Development | 2017년 11월 24일 M | 158,174 | 0 | 0 | $0 |
| Michael Glynn | Chief Commercial Officer | 2012년 2월 15일 A | — | 0 | 0 | $0 |
| Stephen W Turner | VP & Chief Technology Officer | 2011년 7월 11일 J | 1,093,063 | 0 | 0 | $0 |
| Christopher Gibson | 이사 | 2026년 6월 3일 A | 53,913 | 0 | 0 | $0 |
| Hannah Valantine | 이사 | 2026년 6월 3일 A | 22,821 | 0 | 0 | $0 |
| William W. Ericson | 이사 | 2026년 6월 3일 A | 41,616 | 0 | 0 | $0 |
| Christopher M Smith | 이사 | 2026년 6월 3일 A | 54,099 | 0 | 0 | $0 |
| Marshall Mohr | 이사 | 2026년 6월 3일 A | 132,821 | 0 | 0 | $0 |
| Randall S Livingston | 이사 | 2026년 6월 3일 A | 22,821 | 0 | 0 | $0 |
| Kathy Ordonez | 이사 | 2026년 6월 3일 A | 403,037 | 0 | 0 | $0 |
| John F Milligan | 이사 | 2026년 6월 3일 A | 132,821 | 0 | 0 | $0 |
| David B. Singer | 이사 | 2012년 6월 13일 A | — | 0 | 0 | $0 |
| Susan E Siegel | 이사 | 2012년 6월 13일 A | 65,000 | 0 | 0 | $0 |
| Hugh C Martin | 이사 | 2012년 2월 3일 M | 342,458 | 0 | 0 | $0 |
| James R Gibson II | — | 2026년 4월 1일 S | 1,245,663 | 0 | 1 | $-120,813 |
| Michele Farmer | — | 2026년 3월 3일 S | 305,948 | 0 | 3 | $-84,510 |
| Christian O Henry | — | 2026년 3월 3일 S | 3,581,813 | 0 | 3 | $-772,728 |
| Lucy Shapiro | — | 2025년 6월 4일 A | 22,821 | 0 | 0 | $0 |
| Susan G. Kim | — | 2024년 9월 30일 S | 695,654 | 0 | 0 | $0 |
| Jeff Eidel | — | 2024년 8월 19일 S | 869,730 | 0 | 0 | $0 |
| David W Meline | — | 2024년 6월 18일 A | 57,116 | 0 | 0 | $0 |
| David Botstein | — | 2023년 5월 24일 A | 0 | 0 | 0 | $0 |
| Peter Fromen | — | 2022년 3월 2일 A | 190,280 | 0 | 0 | $0 |
| Michael Hunkapiller | — | 2021년 2월 26일 M | 848,405 | 0 | 0 | $0 |
| Eric Schaefer | — | 2021년 2월 22일 S | 88,474 | 0 | 0 | $0 |
| BYERS BROOK H | — | 2016년 5월 17일 A | 110,504 | 0 | 0 | $0 |
| Brian B Dow | — | 2015년 3월 2일 P | 18,119 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 1 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| Magnetar Financial LLC, Magnetar Capital Partners LP, Supernova Management LLC, Alec N. Litowitz ×3 제출 서류 | 2019년 8월 29일 | — | 최초 제출 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 34 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| ARKG · ARK ETF Trust | 1.41% | 10,964,895 NS | 2026년 4월 30일 | N-PORT |
| EVNT · AltShares Trust | 0.75% | 62,040 NS | 2026년 5월 31일 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.41% | 75,049 SH | 2026년 8월 21일 | 일간 |
| GNOM · Global X Funds | 0.40% | 151,435 NS | 2026년 5월 31일 | N-PORT |
| ARKK · ARK ETF Trust | 0.36% | 14,733,201 NS | 2026년 4월 30일 | N-PORT |
| IDNA · iShares Trust | 0.33% | 658,945 SH | 2026년 8월 21일 | 일간 |
| NXTE · INVESTMENT MANAGERS SERIES TRUST II | 0.29% | 98,761 NS | 2026년 6월 30일 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.05% | 1,065,155 SH | 2026년 8월 21일 | 일간 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.03% | 280,941 SH | 2026년 8월 19일 | 일간 |
| IBB · iShares Trust | 0.03% | 2,164,389 SH | 2026년 8월 21일 | 일간 |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.02% | 18,086 SH | 2026년 8월 21일 | 일간 |
| BIB · ProShares Trust | 0.02% | 11,163 NS | 2026년 5월 31일 | N-PORT |
| IWO · iShares Trust | 0.02% | 2,473,318 SH | 2026년 8월 21일 | 일간 |
| RSSL · Global X Funds | 0.01% | 121,533 NS | 2026년 4월 30일 | N-PORT |
| IWM · iShares Trust | 0.01% | 7,238,547 SH | 2026년 8월 21일 | 일간 |
| RB · ProShares Trust | 0.01% | 81 NS | 2026년 5월 31일 | N-PORT |
| ITWO · ProShares Trust | 0.01% | 12,995 NS | 2026년 5월 31일 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 3,579,782 SH | 2026년 8월 19일 | 일간 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 1,624,029 SH | 2026년 8월 19일 | 일간 |
| VHT · VANGUARD WORLD FUND | 0.01% | 727,094 SH | 2026년 8월 19일 | 일간 |
| SCHA · SCHWAB STRATEGIC TRUST | 0.01% | 1,434,895 NS | 2026년 5월 31일 | N-PORT |
| UWM · ProShares Trust | 0.01% | 10,163 NS | 2026년 5월 31일 | N-PORT |
| URTY · ProShares Trust | 0.00% | 10,278 NS | 2026년 5월 31일 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.00% | 9,612 NS | 2026년 5월 31일 | N-PORT |
| HDG · ProShares Trust | 0.00% | 258 NS | 2026년 5월 31일 | N-PORT |
| IWN · iShares Trust | 0.00% | 206,865 SH | 2026년 8월 21일 | 일간 |
| ITOT · iShares Trust | 0.00% | 432,512 SH | 2026년 8월 21일 | 일간 |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 174,278 NS | 2026년 5월 31일 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.00% | 48,231 NS | 2026년 4월 30일 | N-PORT |
| IWV · iShares Trust | 0.00% | 69,080 SH | 2026년 8월 21일 | 일간 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 9,535,565 SH | 2026년 8월 19일 | 일간 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.00% | 17,047 SH | 2026년 8월 19일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 22,805 SH | 2026년 8월 19일 | 일간 |
| DFAC · Dimensional ETF Trust | 0.00% | 8,144 NS | 2026년 4월 30일 | N-PORT |